CME COURSE – ACUTE RESPIRATORY DISTRESS SYNDROME MANAGEMENT IN COVID-19 PATIENTS

This CME program will describe Acute Respiratory Distress Syndrome (ARDS) management strategies and provide an update on ARDS treatment related to COVID-19.

At the end of the course material, you will be required to complete a Knowledge Assessment test based on the coursework and achieve 70% pass rate to successfully complete the activity for AMA PRA Category 1 credit.

– Number of CME credits: 2 AMA PRA Category 1 credits ™ 
– Released:14 December 2020
– Expiration date: 14 December 2021
– Estimated time to complete course: 2 hours

Jointly provided by NYSORA and Postgraduate Institute for Medicine

This activity is suitable for Clinicians, Residents, Fellows, Nurses and other health care and health industry professionals

Learning Objectives:

After completing this activity, the participant should be better able to:

• Define the differences between non-COVID-19-associated ARDS and COVID-19-associated ARDS. 
• Describe clinical treatment concepts for non-COVID-19 and COVID-19-associated ARDS. 
• Identify the differences between ARDS management in non-COVID-19 and COVID-19 patients. 
• Choose the appropriate treatment strategies for non-COVID-19 and COVID-19-associated ARDS patients.